Requirement for a complex array of costimulators in the negative selection of autoreactive thymocytes in vivo

被引:37
作者
Li, RX
Page, DM
机构
[1] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA
关键词
D O I
10.4049/jimmunol.166.10.6050
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoreactive thymocytes can be deleted at an immature stage of their development by Ag-induced apoptosis or negative selection. In addition to Ag, negative selection also requires costimulatory signals from APC. We recently used a fetal thymus organ culture system to show that CD5, CD28, and TNF cooperatively regulate deletion of autoreactive thymocytes. Although these experiments provided strong evidence for the action of several costimulators in negative selection, we wished to demonstrate a role for these molecules in a physiologically natural model where thymocytes are deleted in vivo by endogenously expressed Ags. Accordingly, we examined thymocyte deletion in costimulator-null mice in three models of autoantigen-induced negative selection. We compared CD5(-/-) CD28(-/-) mice to CD40L(-/-) mice, which exhibited a profound block in negative selection in all three systems. Surprisingly, only one of the three models revealed a requirement for the CD5 and CD28 costimulators in autoantigen-induced deletion. These results suggest that an extraordinarily complex array of costimulators is involved in negative selection. We predict that different sets of costimulators will be required depending on the timing of negative selection, the Ag, the signal strength, the APC, and whether Ag presentation occurs on class I or class II MHC molecules.
引用
收藏
页码:6050 / 6056
页数:7
相关论文
共 57 条
[1]  
AIBA Y, 1994, INT IMMUNOL, V6, P1475
[2]   T-cell-receptor affinity and thymocyte positive selection [J].
Alam, SM ;
Travers, PJ ;
Wung, JL ;
Nasholds, W ;
Redpath, S ;
Jameson, SC ;
Gascoigne, NRJ .
NATURE, 1996, 381 (6583) :616-620
[3]  
Ardavin C, 1996, J IMMUNOL, V157, P2789
[4]   B-CELLS ARE ESSENTIAL FOR MURINE MAMMARY-TUMOR VIRUS TRANSMISSION, BUT NOT FOR PRESENTATION OF ENDOGENOUS SUPERANTIGENS [J].
BEUTNER, U ;
KRAUS, E ;
KITAMURA, D ;
RAJEWSKY, K ;
HUBER, BT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1457-1466
[5]   Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes [J].
Biancone, L ;
Bowen, MA ;
Lim, A ;
Aruffo, A ;
Andres, G ;
Stamenkovic, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :811-819
[6]   A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5 [J].
Bikah, G ;
Lynd, FM ;
Aruffo, AA ;
Ledbetter, JA ;
Bondada, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (08) :1185-1196
[7]  
BILL J, 1990, J MOL CELL IMMUNOL, V4, P269
[8]  
BURKLY LC, 1993, J IMMUNOL, V151, P3954
[9]  
Chan S, 1999, EUR J IMMUNOL, V29, P2916, DOI 10.1002/(SICI)1521-4141(199909)29:09<2916::AID-IMMU2916>3.0.CO
[10]  
2-I